✦ LIBER ✦

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

✍ Scribed by Frank R. Dunphy; Gary Spitzer; Jane E. Rossiter Fornoff; Jonathan C. Yau; Susan D. Huan; Karel A. Dicke; Aman U. Buzdar; Gabriel N. Hortobagyi

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 856 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940415)73:8<2157::aid-cncr2820730821>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term disease-free survival in a chi

Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues

✍ Devalck, Christine ;Tempels, Didier ;Ferster, Alina ;De Laet, Marc-Henri ;Bujan, 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract We report the case of a 8‐month‐old girl who presented with a metastatic malignant germ cell tumor (MGCT) that proved to be resistant to chemotherapy, including salvage platinum‐based combination therapy, surgery, and metastatectomy. The child was then treated with high‐dose carboplatin

Monitoring of disseminated tumor cells i

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

✍ Vilde Drageset; Jahn M. Nesland; Bjorn Erikstein; Eva Skovlund; Hilde Sommer; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 1 views

## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent

Results and long term follow-up for 1581

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy : A reference

✍ Zia U. Rahman; Debbie K. Frye; Terry L. Smith; Lina Asmar; Richard L. Theriault; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

The authors report results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with doxorubicin-containing combination chemotherapy at a single institution; this report is meant to serve as a reliable reference for single-arm studies of newer therapies in this patient

Quality of life among patients with Stag

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy : Results from Cancer and Leukemia Group B 9066

✍ Jeffrey Peppercorn; James Herndon II; Alice B. Kornblith; William Peters; Tim Ah 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either high‐dose chemotherapy with autologous stem cell support (HDC) o